Oral oncology · 2012
Long-term success of surgery in bisphosphonate-related osteonecrosis of the jaws (BRONJs).
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Holzinger Daniel, Seemann Rudolf, Klug Clemens, Ewers Rolf, Millesi Gabriele, Baumann Arnulf, Wutzl Arno
Аннотация
OBJECTIVES: Bisphosphonates are associated with osteonecrosis of the jaw. Bisphosphonate-related osteonecrosis of the jaw (BRONJ) may be treated conservatively or by surgery.
PATIENTS AND METHODS: 108 patients underwent surgery and 88 patients were followed for a mean period of 337 days. Age, gender, dental procedures, underlying disease, and the role of bisphosphonate treatment in the success of surgery were evaluated retrospectively.
RESULTS: Surgical treatment improved the stage distribution from 19% stage I, 56% stage II and 25% stage III to 59% intact mucosa, 19% stage I and 13% stage II and 8% stage III. The improvement in the stage of disease achieved by surgery was statistically significant. Further relevant parameters that favor a positive outcome of surgery were the event triggering the outbreak of BRONJ (p=0.05) and the underlying disease (p=0.05). BRONJ in the maxilla necessitated repeat surgery significantly earlier than did BRONJ in the mandible (p=0.03).
CONCLUSION: Effective surgery might improve the outcome of BRONJ, although prevention still is the most important aspect of this condition.
PATIENTS AND METHODS: 108 patients underwent surgery and 88 patients were followed for a mean period of 337 days. Age, gender, dental procedures, underlying disease, and the role of bisphosphonate treatment in the success of surgery were evaluated retrospectively.
RESULTS: Surgical treatment improved the stage distribution from 19% stage I, 56% stage II and 25% stage III to 59% intact mucosa, 19% stage I and 13% stage II and 8% stage III. The improvement in the stage of disease achieved by surgery was statistically significant. Further relevant parameters that favor a positive outcome of surgery were the event triggering the outbreak of BRONJ (p=0.05) and the underlying disease (p=0.05). BRONJ in the maxilla necessitated repeat surgery significantly earlier than did BRONJ in the mandible (p=0.03).
CONCLUSION: Effective surgery might improve the outcome of BRONJ, although prevention still is the most important aspect of this condition.
Предметные рубрики MeSH
Anti-Bacterial AgentsAnti-Infective Agents, LocalBisphosphonate-Associated Osteonecrosis of the JawBone Density Conservation AgentsBreast NeoplasmsChlorhexidineDental ImplantsDenturesFemaleFollow-Up StudiesHumansHydrogen PeroxideLongitudinal StudiesMaleMandibular DiseasesMaxillary DiseasesMultiple MyelomaNeoplasmsOsteoporosisReoperationRetrospective StudiesTooth ExtractionTreatment OutcomeWound Healing